Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Management of Constipation with PEG 3350 and Rectal Therapy

Initial Assessment and Contraindications

  • The American Society of Clinical Oncology recommends ruling out bowel obstruction or paralytic ileus before adding rectal therapy, as they are contraindications to rectal interventions 1
  • The National Comprehensive Cancer Network recommends checking for fecal impaction, which may require manual disimpaction or enema rather than suppository 1, 2
  • Adequate PEG dosing, confirmed by taking 17g daily mixed in 8 ounces of liquid, and adequate fluid intake are essential for PEG to work effectively, as stated by the American Gastroenterological Association 3

Rationale for Adding Rectal Therapy

  • The American Society of Clinical Oncology recommends enemas and suppositories when oral treatment fails after several days to prevent fecal impaction 1
  • Bisacodyl suppositories provide a stimulant laxative effect through both motor and secretory actions on the colon, working within hours, according to the American Society of Clinical Oncology 1
  • The combination approach uses different mechanisms, with PEG working osmotically while suppositories provide direct rectal stimulation, as recommended by the National Comprehensive Cancer Network 1, 2
  • The American Gastroenterological Association recommends continuing PEG 3350 at 17g daily with 8 ounces of liquid for the first 3 days 3
  • If no bowel movement occurs by day 3-4, adding a bisacodyl suppository (10mg) or glycerin suppository is recommended, along with continuing PEG 3350 at the same dose, as stated by the American Society of Clinical Oncology and the National Comprehensive Cancer Network 1, 2

Long-Term Management Considerations

  • The American Gastroenterological Association recommends continuing PEG 3350 as maintenance therapy once a bowel movement is achieved, as the response is durable over 6 months 3
  • The National Comprehensive Cancer Network suggests considering adding an oral stimulant laxative (senna or bisacodyl) to PEG if recurrent issues occur 1, 2
  • A prophylactic bowel regimen, including a stimulant laxative with or without a stool softener plus PEG, is essential, as recommended by the National Comprehensive Cancer Network 2

Common Pitfalls to Avoid

  • The American Gastroenterological Association advises against assuming PEG failure without confirming adequate dosing and fluid intake, as many patients do not mix with sufficient liquid 3
  • The American Society of Clinical Oncology recommends not delaying rectal intervention beyond 3-4 days, as the risk of fecal impaction increases 1
  • The American Society of Clinical Oncology also advises against using suppositories in patients on anticoagulation without assessing bleeding risk, due to the risk of rectal bleeding or intramural hematoma 1
  • The National Comprehensive Cancer Network recommends not adding fiber supplements when PEG fails, as fiber is ineffective for established constipation and may worsen symptoms 2